Medicamen Biotech consolidated net profit rises 82.88% in the September 2025 quarter
(15 Nov 2025)
Back
Net profit of Medicamen Biotech rose 82.88% to Rs 2.67 crore in the quarter ended September 2025 as against Rs 1.46 crore during the previous quarter ended September 2024. Sales rose 5.43% to Rs 47.17 crore in the quarter ended September 2025 as against Rs 44.74 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | | Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 47.17 | 44.74 | 5 |
| OPM % | 10.94 | 11.87 | - |
| PBDT | 4.54 | 4.56 | 0 |
| PBT | 2.68 | 1.96 | 37 |
| NP | 2.67 | 1.46 | 83 |
|